Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.7%

2 terminated out of 26 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

19%

5 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (16)
P 2 (2)
P 3 (1)
P 4 (4)

Trial Status

Completed12
Unknown4
Recruiting3
Not Yet Recruiting2
Active Not Recruiting2
Terminated2

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT06898879Not ApplicableNot Yet Recruiting

Enhancing Veteran-Clinical Collaboration in VA PRRCs

NCT05416658Not ApplicableNot Yet Recruiting

Shared Decision Making for Antipsychotic Medications

NCT06740383Recruiting

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

NCT04324944Not ApplicableCompleted

Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness

NCT05756855Not ApplicableActive Not Recruiting

Young Adults With Violent Behavior During Early Psychosis (Aim 2)

NCT04916626Not ApplicableActive Not Recruiting

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

NCT04323566Phase 2Enrolling By Invitation

Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement

NCT06423651Not ApplicableRecruiting

Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

NCT06005766Not ApplicableRecruiting

The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care

NCT04874974Not ApplicableCompleted

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

NCT06007105Not ApplicableUnknown

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

NCT00716755Not ApplicableCompleted

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

NCT03559426Phase 4Completed

Research Into Antipsychotic Discontinuation and Reduction Trial

NCT04783285Not ApplicableCompleted

Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders

NCT01888627Not ApplicableUnknown

Integrated Care in Psychotic Disorders With Severe Mental Illness

NCT00644800Phase 4Completed

A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

NCT01981759Phase 4Completed

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

NCT02787122Not ApplicableCompleted

Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia

NCT01822418Phase 4Completed

Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)

NCT00222807Completed

Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus

Scroll to load more

Research Network

Activity Timeline